🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🎥#SCAIRDN Program Chair Tai Kobayashi, discusses program highlights and what to look forward to in the course on June 6 in Houston. Register today to learn how to build an optimal #RDN program and improve hypertension treatment for your patients.🏥 🔗 bit.ly/SCAIRDN2025

📈By attending #SCAIRDN on June 6 in Houston you will have the opportunity increase your expertise in #Hypertension management and understand how to build a #RDN program. Tai Kobayashi shares 3 course takeaways in this video.🎥 Learn more and register➡️ bit.ly/SCAIRDN2025

📅#SCAIRDN kicks off in one week! We can't wait to see everyone in Houston. There is still time to register and attend. Our expert faculty will teach you how to build a successful #RDN program.💪 Register now➡️ bit.ly/SCAIRDN2025 #RenalDenervation #InterventionalCardiology

🚀 Tai Kobayashi launches our very first SCAI Renal Denervation Regional Course in Houston! Stay tuned for live updates throughout the day. #SCAIRDN #InterventionalCardiology #RenalDenervation

What is the state of uncontrolled hypertension & what are the current guidelines? Dr. Michael J. Bloch breaks it down at #SCAIRDN. #Hypertension #RenalDenervation

How well should #hypertension therapies work & what do we know about linking health outcomes to #BloodPressure reduction?​ Katherine Kunkel, MD, FSCAI, takes a closer look at #SCAIRDN

What does the evidence say about #RDN? Dr. Kamal Gupta, FSCAI Kamal Gupta shares key insights on trial designs, follow up, guidelines, & approved FDA devices at #SCAIRDN. #Hypertension #RenalDenervation

What is the patient's preference? Kamal Gupta also highlights the important role of patient preferences in shaping #hypertension treatment strategies at #SCAIRDN💡

Live now at #SCAIRDN attendees roll up their sleeves for hands-on training w #RDN & #uRDN techniques. #HypertensionCare #RenalDenervation Tai Kobayashi Kamal Gupta

Experts dive into #HypertensionCare in the clinic. Kicking things off, Dr. Michael Bloch outlines the key steps in clinical workup & patient selection. #Hypertension #SCAIRDN

Reaching underserved populations with remote monitoring is possible— Trey Clark, MD, MPH Trey Clark, MD MPH shares how it can be done and why it matters📢 #SCAIRDN #HypertensionCare #Hypertension

Dr. Michael J. Bloch at #SCAIRDN: Who is the right candidate for #RDN? 🩺Explore the full patient pathway—from pre- to post-procedure—and how shared decision-making plays a critical role in identifying potential candidates. #RenalDenervation #Hypertension

How to start a #RDN program? It’s not just about the $$$ — it’s also about the clinical impact. Matheen Khuddus, MD, FSCAI Matheen Khuddus breaks down what it takes to add #RDN to your service line, key admin needs that everyone should know, & reimbursement highlights. #SCAIRDN

Dr. Eric Secemsky, FSCAI Eric Secemsky MD MSc at #SCAIRDN: anatomy and technology overview, procedural strategies, and a real-world #RDN case featuring a deep dive into #rRDN device details & practical how-to insights.

To close out the day, attendees of the #SCAIRDN program take part in hands-on training focused on both #rRDN and #uRDN techniques. #HypertensionCare #RenalDenervation Tai Kobayashi Kamal Gupta Trey Clark, MD MPH

A big thank you to everyone who joined our special #RDN regional course! We're looking forward to continuing the work together to expand #HypertensionCare to more patients. #SCAIRDN #RenalDenervation #Hypertension Tai Kobayashi Kamal Gupta Trey Clark, MD MPH

Excited to announce our collaboration with the American College of Cardiology to expand the BIDMC CVI BIDMC Smith Center Renal Denervation Registry as part of the NCDR CathPCI module. acc.org/Latest-in-Card… The Smith Center RDN Registry is a nationwide multicenter registry collecting early procedural

Congratulations to Dr. Raj Jain who received the William Wikoff Smith endowed Chair in Cardiovascular Research from his mentor Dean Jonathan Epstein! ⁦Penn Medicine⁩

Renal denervation for HTN was approved the FDA over 18 months ago. But very few cases performed in the US despite a theoretical eligible population >100M patients for this therapy. We cover the elephant in the room: reimbursement in Cardiac Interventions Today. citoday.com/articles/2025-…

Drs. Catherine Vanchiere, Tayyab Shah (Tayyab Shah), Debbie L. Cohen, Jay Giri (Jay Giri), Brian Fulton, & Taisei Kobayashi (Tai Kobayashi), discuss the state of reimbursement for RDN in the US. citoday.com/articles/2025-…